“…In our previous study, the antimicrobial effect of native buforin I was assessed against same microbial strains (MIC for L. monocytogenes, S. aureus, A. niger, C. albicans, P. aeruginosa, S. aureus (MRSA), E. coli O157:H7, S. Typhi, K. pneumonia and C. perfringens was 4, 10, 10, 10, 12, 14, 14, 14, 6, and 16 (µg/mL) of buforin I, respectively) 7 . As the difference in MICs value for the buforin I and recombinant buforin I for all microbial strains were less than two-fold, the sensitivity levels were considered equal, therefore, there is no significant difference between the antimicrobial effect of recombinant buforin I and synthetic buforin I.…”